CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three and nine-month periods ended September 30, 2013, and provided a clinical update.
http://www.freshnews.com/news/862758/cytrx-reports-2013-third-quarter-financial-results
http://www.freshnews.com/news/862758/cytrx-reports-2013-third-quarter-financial-results
No comments:
Post a Comment